This hormone bioprocessing inhibits obesity by regulating the production of CRH, which is responsible for controlling stress levels in the body, and the receptor complex can be used to identify potential anti-obesity receptors such as the Neuropeptide Y (NPY) receptor for researching new effective obesity drugs to treat obesity. Here, CRH is linked to obesity due to melanocortin 4 receptor deficiency.